Orphagen Pharmaceuticals Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Employees
  • 13
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 7

Orphagen Pharmaceuticals General Information

Description

Developer of small molecule drugs designed to treat certain orphan nuclear receptors. The company's drugs treat psoriasis and other autoimmune diseases such as adrenocortical cancer and Cushing's syndrome as well as ovarian, pancreatic and liver cancer, enabling screening services to identify, characterize and position a new class of drug.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 11558 Sorrento Valley Road
  • Suite 4
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Orphagen Pharmaceuticals Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Orphagen Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-Jul-2020 Completed Clinical Trials - Phase 1
7. Debt - PPP 03-May-2020 Completed Clinical Trials - Phase 1
6. Grant 01-Sep-2019 00.000 Completed Clinical Trials - Phase 1
5. Grant 28-May-2013 00000 Completed Generating Revenue
4. Grant 16-Jul-2012 00000 Completed Generating Revenue
3. Grant 21-Sep-2011 00000 Completed Generating Revenue
2. Grant 29-Oct-2010 $2.7M Completed Generating Revenue
1. Grant 01-Jan-2009 $4.03M Completed Generating Revenue
To view Orphagen Pharmaceuticals’s complete valuation and funding history, request access »

Orphagen Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of small molecule drugs designed to treat certain orphan nuclear receptors. The company's drugs treat psoriasi
Drug Discovery
San Diego, CA
13 As of 2021
0000000000 0

0000000

iscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ven
0000 000000000
Barcelona, Spain
00 As of 0000
000.00
000000000000 000.00

00000000

m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
000000000000000
San Diego, CA
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Orphagen Pharmaceuticals Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Venture Capital-Backed Barcelona, Spain 00 000.00 000000000000 000.00
000000000 Formerly VC-backed San Diego, CA 00 00000 00000000 00000
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
00000000 000000000 Corporation West Conshohocken, PA 00 000.00 000000 - 000 000.00
000000000 00000000 Formerly VC-backed Tarrytown, NY 0000 00000 00000000000 00000
You’re viewing 5 of 8 competitors. Get the full list »

Orphagen Pharmaceuticals Executive Team (5)

Name Title Board Seat Contact Info
Scott Thacher Ph.D Founder, Chief Executive Officer & Board Member
Michelle Youngers Chief Operating Officer
Paul Crowe Ph.D Vice President of Drug Discovery
Neil Raheja Director of Chemistry
You’re viewing 4 of 5 executive team members. Get the full list »

Orphagen Pharmaceuticals Board Members (9)

Name Representing Role Since
Brian Culley Self Board Member 000 0000
David Snyder JD Self Board Member 000 0000
Gonul Velicelebi Ph.D Self Board Member 000 0000
Leonard Post Ph.D Self Board Member 000 0000
Scott Thacher Ph.D Orphagen Pharmaceuticals Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Orphagen Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orphagen Pharmaceuticals Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Vencore Capital Venture Capital Minority 000 0000 000000 0
Eunice Kennedy Shriver National Institute of Child Health and Human Development Government 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
National Heart, Lung and Blood Institute Government 000 0000 000000 0
The National Institute of Diabetes and Digestive and Kidney Diseases Government 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »